Latest Insider Transactions at Repligen Corp (RGEN)
This section provides a real-time view of insider transactions for Repligen Corp (RGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REPLIGEN CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REPLIGEN CORP's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 02
2023
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
6,670
-3.87%
|
$1,173,920
$176.37 P/Share
|
Mar 02
2023
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
630
-2.11%
|
$109,620
$174.37 P/Share
|
Feb 28
2023
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
6,021
-1.7%
|
$1,041,633
$173.36 P/Share
|
Feb 28
2023
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
912
-1.49%
|
$157,776
$173.36 P/Share
|
Feb 28
2023
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
816
-2.14%
|
$141,168
$173.36 P/Share
|
Feb 28
2023
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,203
-2.07%
|
$208,119
$173.36 P/Share
|
Feb 28
2023
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
594
-6.1%
|
$102,762
$173.44 P/Share
|
Feb 16
2023
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,647
-16.15%
|
$1,129,400
$200.0 P/Share
|
Feb 06
2023
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
111
+50.0%
|
-
|
Nov 11
2022
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
25,000
-12.3%
|
$5,000,000
$200.0 P/Share
|
Nov 11
2022
|
Anthony Hunt |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+10.95%
|
$825,000
$33.87 P/Share
|
Oct 07
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
466
+1.32%
|
$27,494
$59.52 P/Share
|
Sep 09
2022
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
775
-1.0%
|
$175,925
$227.17 P/Share
|
Sep 08
2022
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
26,402
-1.7%
|
$5,887,646
$223.76 P/Share
|
Sep 08
2022
|
Anthony Hunt |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.66%
|
$330,000
$33.87 P/Share
|
Aug 16
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,698
-8.47%
|
$1,687,896
$252.93 P/Share
|
Aug 16
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,017
+4.67%
|
$602,550
$150.84 P/Share
|
Aug 11
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
4,840
-10.32%
|
$1,229,360
$254.67 P/Share
|
Aug 11
2022
|
Ralf Kuriyel Senior VP, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+5.45%
|
$236,000
$59.56 P/Share
|
Aug 04
2022
|
Christine Gebski |
SELL
Open market or private sale
|
Direct |
3,357
-9.85%
|
$815,751
$243.01 P/Share
|
Aug 03
2022
|
James Bylund Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,000
-17.05%
|
$480,000
$240.4 P/Share
|
Aug 03
2022
|
James Bylund Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+14.56%
|
$188,000
$94.33 P/Share
|
Aug 01
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,000
-5.1%
|
$440,000
$220.0 P/Share
|
Jul 21
2022
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
24,802
-11.3%
|
$4,960,400
$200.0 P/Share
|
Jul 21
2022
|
Anthony Hunt |
BUY
Exercise of conversion of derivative security
|
Direct |
20,154
+4.42%
|
$665,082
$33.14 P/Share
|
May 26
2022
|
Manner Carrie Eglinton |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+40.88%
|
-
|
May 26
2022
|
Glenn P Muir |
BUY
Grant, award, or other acquisition
|
Direct |
534
+7.19%
|
-
|
May 26
2022
|
Nicolas Barthelemy |
BUY
Grant, award, or other acquisition
|
Direct |
534
+20.42%
|
-
|
May 26
2022
|
Karen A Dawes |
BUY
Grant, award, or other acquisition
|
Direct |
644
+0.83%
|
-
|
May 26
2022
|
Konstantin Konstantinov |
BUY
Grant, award, or other acquisition
|
Direct |
534
+50.0%
|
-
|
May 26
2022
|
Rohin Mhatre |
BUY
Grant, award, or other acquisition
|
Direct |
1,202
+42.01%
|
-
|
May 25
2022
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
14,715
-3.42%
|
$2,221,965
$151.1 P/Share
|
May 13
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
712
-1.78%
|
$106,800
$150.4 P/Share
|
May 13
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
335
-0.97%
|
$50,250
$150.4 P/Share
|
May 13
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
712
-3.42%
|
$106,800
$150.4 P/Share
|
Apr 01
2022
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
335
-3.33%
|
$62,980
$188.02 P/Share
|
Mar 16
2022
|
Manner Carrie Eglinton |
BUY
Open market or private purchase
|
Direct |
625
+22.89%
|
$109,375
$175.02 P/Share
|
Mar 08
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+5.02%
|
$191,636
$46.7 P/Share
|
Mar 01
2022
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
7,292
-3.53%
|
$1,414,648
$194.06 P/Share
|
Mar 01
2022
|
Thomas F Ryan Jr Director |
SELL
Open market or private sale
|
Direct |
2,000
-34.81%
|
$396,000
$198.03 P/Share
|
Mar 01
2022
|
Thomas F Ryan Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+22.44%
|
$38,000
$38.76 P/Share
|
Feb 28
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
598
-1.71%
|
$117,208
$196.7 P/Share
|
Feb 28
2022
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
16,538
-3.86%
|
$3,241,448
$196.7 P/Share
|
Feb 28
2022
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
30,074
+12.03%
|
-
|
Feb 28
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,129
-4.23%
|
$613,284
$196.7 P/Share
|
Feb 28
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,922
+13.42%
|
-
|
Feb 28
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,057
-4.8%
|
$403,172
$196.7 P/Share
|
Feb 28
2022
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
4,234
+15.89%
|
-
|
Feb 27
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-1.3%
|
$90,552
$196.7 P/Share
|
Feb 27
2022
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
2,754
-1.41%
|
$539,784
$196.7 P/Share
|